MuRF2 regulates PPARγ1 activity to protect against diabetic cardiomyopathy and enhance weight gain induced by a high fat diet

作者: Jun He , Megan T Quintana , Jenyth Sullivan , Traci L Parry , Trisha J Grevengoed

DOI: 10.1186/S12933-015-0252-X

关键词: Heart diseaseInsulin resistanceEndocrinologyTranscription factorInternal medicineDiabetic cardiomyopathyDiabetes mellitusPeroxisome proliferator-activated receptorSkeletal muscleUbiquitin ligaseMedicineEndocrinology, Diabetes and MetabolismCardiology and Cardiovascular Medicine

摘要: In diabetes mellitus the morbidity and mortality of cardiovascular disease is increased represents an important independent mechanism by which heart exacerbated. The pathogenesis diabetic cardiomyopathy involves enhanced activation PPAR transcription factors, including PPARα, to a lesser degree PPARβ PPARγ1. How these factors are regulated in largely unknown. Recent studies have described post-translational ubiquitination PPARs as ways activity inhibited cancer. However, specific mechanisms not previously been described. implicated muscle-specific ubiquitin ligase muscle ring finger-2 (MuRF2) inhibiting nuclear factor SRF. Initial MuRF2−/− hearts revealed activity, leading hypothesis that MuRF2 regulates ubiquitination. mice were challenged with 26-week 60% fat diet designed simulate obesity-mediated insulin resistance cardiomyopathy. Mice followed conscious echocardiography, blood glucose, tissue triglyceride, glycogen levels, immunoblot analysis intracellular signaling, skeletal morphometrics, PPARβ, PPARγ1-regulated mRNA expression. protein levels increase ~20% during development induced high diet. Compared littermate wildtype hearts, exhibit exaggerated cardiomyopathy, characterized early onset systolic dysfunction, larger left ventricular mass, higher weight. had significantly PPARα- gene expression RT-qPCR, consistent MuRF2’s regulation vivo. Mechanistically, mono-ubiquitinated PPARα PPARγ1 vitro, its non-degradatory role increasing MuRF2:PPARγ1 (>5:1) beyond physiological drove poly-ubiquitin-mediated degradation indicating large increases may lead if found other states. Mutations contribute severity familial hypertrophic present study suggests lack MuRF2, patients, can result These also identify first regulate cardiac activities vivo via modification without degradation.

参考文章(113)
Jessica E. Rodríguez, Jie-Ying Liao, Jun He, Jonathan C. Schisler, Christopher B. Newgard, Doreen Drujan, David J. Glass, C. Brandon Frederick, Bryan C. Yoder, David S. Lalush, Cam Patterson, Monte S. Willis, The ubiquitin ligase MuRF1 regulates PPARα activity in the heart by enhancing nuclear export via monoubiquitination. Molecular and Cellular Endocrinology. ,vol. 413, pp. 36- 48 ,(2015) , 10.1016/J.MCE.2015.06.008
Keisuke Mochida, Yu Oikawa, Yayoi Kimura, Hiromi Kirisako, Hisashi Hirano, Yoshinori Ohsumi, Hitoshi Nakatogawa, Receptor-mediated selective autophagy degrades the endoplasmic reticulum and the nucleus Nature. ,vol. 522, pp. 359- 362 ,(2015) , 10.1038/NATURE14506
Monte S. Willis, Kristine M. Wadosky, Jessica E. Rodríguez, Jonathan C. Schisler, Pamela Lockyer, Eleanor G. Hilliard, David J. Glass, Cam Patterson, Muscle ring finger 1 and muscle ring finger 2 are necessary but functionally redundant during developmental cardiac growth and regulate E2F1-mediated gene expression in vivo. Cell Biochemistry and Function. ,vol. 32, pp. 39- 50 ,(2014) , 10.1002/CBF.2969
Sihao Liu, Ben Hatano, Minghui Zhao, Chen-Chung Yen, Kihwa Kang, Shannon M. Reilly, Matthew R. Gangl, Cem Gorgun, James A. Balschi, James M. Ntambi, Chih-Hao Lee, Role of peroxisome proliferator-activated receptor {delta}/{beta} in hepatic metabolic regulation. Journal of Biological Chemistry. ,vol. 286, pp. 1237- 1247 ,(2011) , 10.1074/JBC.M110.138115
Oliver Fiehn, Gert Wohlgemuth, Martin Scholz, Tobias Kind, Do Yup Lee, Yun Lu, Stephanie Moon, Basil Nikolau, Quality control for plant metabolomics: reporting MSI‐compliant studies Plant Journal. ,vol. 53, pp. 691- 704 ,(2008) , 10.1111/J.1365-313X.2007.03387.X
Christophe Bauters, Nicolas Lamblin, Eugène P Mc Fadden, Eric Van Belle, Alain Millaire, Pascal de Groote, Influence of diabetes mellitus on heart failure risk and outcome Cardiovascular Diabetology. ,vol. 2, pp. 1- 16 ,(2003) , 10.1186/1475-2840-2-1
Markus Rieck, Lena Wedeken, Sabine Müller-Brüsselbach, Wolfgang Meissner, Rolf Müller, Expression level and agonist‐binding affect the turnover, ubiquitination and complex formation of peroxisome proliferator activated receptor β FEBS Journal. ,vol. 274, pp. 5068- 5076 ,(2007) , 10.1111/J.1742-4658.2007.06037.X
Ting-I. Lee, Yu-Hsun Kao, Yao-Chang Chen, Nan-Hung Pan, Yi-Jen Chen, Oxidative stress and inflammation modulate peroxisome proliferator‐activated receptors with regional discrepancy in diabetic heart European Journal of Clinical Investigation. ,vol. 40, pp. 692- 699 ,(2010) , 10.1111/J.1365-2362.2010.02318.X
Jose A. Madrazo, Daniel P. Kelly, The PPAR trio: Regulators of myocardial energy metabolism in health and disease Journal of Molecular and Cellular Cardiology. ,vol. 44, pp. 968- 975 ,(2008) , 10.1016/J.YJMCC.2008.03.021
Bianca Hemmeryckx, Marijke Gaekens, David J. Gallacher, Hua Rong Lu, Henri Roger Lijnen, Effect of Rosiglitazone on Liver Structure and Function in Genetically Diabetic Akita Mice Basic & Clinical Pharmacology & Toxicology. ,vol. 113, pp. 353- 360 ,(2013) , 10.1111/BCPT.12104